Interventional cardiology devices are primarly related to heart disease, and most of the heart diseases have some serious medical conditions, such as angina, congestive heart failure, and arrhythmias. These are often caused by partially blocked coronary arteries, which is the most common cause of death globally. Since the 1980s, balloon angioplasty has been the standard method for treating coronary artery disease.Coronary artery disease (CAD) blocks the artery that supplies blood to the heart. It occurs when the coronary artery is narrowed or blocked with the formation of plaque,which forms due to reasons such as cholesterol, fatty deposits, calcium, and other substances.

PART 01: Executive summary 6

PART 02: Scope of the report 16

Top-vendor offerings 17

PART 03: Market research methodology 26

Research methodology 26

Economic indicators 26

PART 04: Introduction 27

Key market highlights 27

Market snapshot 32

PART 05: Market landscape 34

Market overview 34

Market size and forecast 35

Five forces analysis 40

PART 06: Market segmentation by product type 41

Coronary stents 41

PTCA balloon catheters 42

Interventional guide wires 42

Interventional cardiology imaging systems 43

LAA closure devices 43

Atherectomy devices 43

PART 07: Global coronary stents market 45

Market overview 45

Market size and forecast 45

PART 08: Global interventional cardiology PTCA balloon

catheter market 48

Market overview 48

Market size and forecast 48

PART 09: Global interventional cardiology guide wires

market 51

Market overview 51

Market size and forecast 51

PART 10: Global interventional cardiology imaging

systems markets 53

Market overview 53

Market size and forecast 54

PART 11: Global LAA closure devices market 56

Market overview 56

Market size and forecast 56

PART 12: Global atherectomy devices 59

Market overview 59

Market size and forecast 59

PART 13: Market segmentation by end-user 63

ASCs 63

Hospitals 66

Physicians' offices 67

PART 14: Geographical segmentation 68

Interventional cardiology market in Americas 69

Interventional cardiology market in EMEA 70

Interventional cardiology market in APAC 71

PART 15: Market drivers 73

Increasing incidences of cardiac disorders and rise in

older population 73

Advances in technology 74

Growing demand for MI procedures 75

Favorable reimbursement policies 76

PART 16: Impact of drivers 78

PART 17: Market challenges 79

High cost of interventional cardiology procedures 79

Complications associated with usage of interventional

cardiology devices 80

Stringent regulation for approval of devices 81

Pricing pressure coupled with lack of product

differentiation 82

PART 18: Impact of drivers and challenges 83

PART 19: Market trends 84

Emergence of bioabsorbable stents 84

Increase in M&A 85

Growing popularity of hybrid procedures 87

Focus on emerging countries 87

PART 20: Vendor landscape 89

Competitive scenario 89

PART 21: Key vendor analysis 96

Abbott Vascular 96

Boston Scientific 100

Cordis 104

Medtronic 108

St. Jude Medical 111

Other prominent vendors 115

PART 22: Appendix 120

List of abbreviations 120

PART 23: Explore Technavio 121